News &amp; Updates

Many adolescents with obesity who are seeking treatment self-report symptoms of depression, eating disorders, and/or binge eating, and these symptoms appear to decrease with weight loss, according to a study.

Obesity treatment interventions also help address mental health conditions

Inflammatory biomarkers may pinpoint people at high-risk of psychiatric disorders

Inflammatory biomarkers such as leukocytes, haptoglobin, C-reactive protein (CRP), and immunoglobulin G (IgG) appear to be associated with a subsequent risk of psychiatric disorders and may thus aid in identifying high-risk populations, according to a study.

Inflammatory biomarkers may pinpoint people at high-risk of psychiatric disorders

Urinary incontinence linked to postpartum depression

The risk of postpartum depression (PPD) appears to increase by as much as 45 percent in the presence of urinary incontinence, according to the results of a meta-analysis.

Urinary incontinence linked to postpartum depression

Original New Drug Application Approvals by US FDA (1-15 August 2024)

New drug applications approved by US FDA as of 1-15 August 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 August 2024)

EAT-Lancet diet inversely tied to incident depression, anxiety

23 Aug 2024 by

A higher adherence to the EAT-Lancet reference diet is associated with lower risks of incident depression, anxiety, and their co-occurrence, suggests a study.

EAT-Lancet diet inversely tied to incident depression, anxiety

23 Aug 2024

Early intervention program cuts suicide, self-harm rates in schizophrenia

16 Aug 2024

Among patients with first-episode schizophrenia, an extended early intervention service may lower the incidence of suicide and self-harm, according to a study.

Early intervention program cuts suicide, self-harm rates in schizophrenia

16 Aug 2024

Adjunctive brexpiprazole benefits seen in Asian adults with MDD in real-world

15 Aug 2024 by

Up to 3 months of treatment with adjunctive brexpiprazole helps with symptom severity in Asian adults with major depressive disorder (MDD) and inadequate response to antidepressants in a real-life clinical setting in Singapore.

Adjunctive brexpiprazole benefits seen in Asian adults with MDD in real-world

15 Aug 2024

Transmission of parental psychiatric conditions extends to nonpsychiatric outcomes in children

Parents with a psychiatric disorder may transmit not only such condition but also nonpsychiatric outcomes to their offspring, suggests a study.

Transmission of parental psychiatric conditions extends to nonpsychiatric outcomes in children

ALTO program fails to lower opioid prescribing in trauma patients

Implementation of a hospital-wide Alternatives to Opiates (ALTO) program falls short of reducing in-hospital or discharge opioid prescribing, reports a study.

ALTO program fails to lower opioid prescribing in trauma patients